Latest News in the pharma Industry

All

CDMO Vetter bundles development labs into Ravensburg facility

CDMO Vetter bundles development labs into Ravensburg facility

30 Jan 2020

Vetter has increased development capacity by bringing all its laboratories together into its 1,800 square metre Ravensburg site in Germany, the contract manufacturing and development organisation (CDMO) said Thursday.

Read more 
Dr Reddy’s receives five FDA observations on Srikakulam API plant

Dr Reddy’s receives five FDA observations on Srikakulam API plant

29 Jan 2020

The US Food and Drug Administration has issued India’s Dr Reddy’s Laboratories with five observations after a recent inspection at its active pharmaceutical ingredient (API) manufacturing plant at Srikakulam.

Read more 
Digital value-added medicines - a key driver for 2020

Digital value-added medicines - a key driver for 2020

29 Jan 2020

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

Read more 
Merck KGaA invests Eur250 million in Swiss manufacturing and R&D facility

Merck KGaA invests Eur250 million in Swiss manufacturing and R&D facility

28 Jan 2020

German company Merck KGaA is investing Euro 250 million in a Swiss biologics facility that bridges manufacturing and research.

Read more 
Careers in Chemical Manufacturing:  From benchtop chemistry to the installation of bespoke manufacturing technology

Careers in Chemical Manufacturing: From benchtop chemistry to the installation of bespoke manufacturing technology

28 Jan 2020

As manufacturing industries continue to promote the diverse roles available in science, technology, engineering and mathematics (STEM) disciplines, we turn the spotlight on careers in chemical manufacturing

Read more 
Nabis and Panaxia form JV to launch pharma grade cannabis products in Arizona

Nabis and Panaxia form JV to launch pharma grade cannabis products in Arizona

28 Jan 2020

Canadian investment firm Nabis Holdings said Tuesday it has agreed to form a joint venture with Israeli pharmaceutical company Panaxia to launch a range of cannabis-based pharmaceutical products in the US state of Arizona in the second half of 2020.

Read more 
Cognate completes purchase of advanced therapy CDMO Cobra

Cognate completes purchase of advanced therapy CDMO Cobra

28 Jan 2020

Cognate BioServices, a contract development and manufacturing organization specialising in cell and gene therapy, has completed its purchase of Cobra Biologics, a CDMO specialized in providing development and manufacturing services for plasmid DNA and ...

Read more 
CNS completes API pilot manufacturing to take Berubicin closer to clinical trials

CNS completes API pilot manufacturing to take Berubicin closer to clinical trials

28 Jan 2020

Biotech firm CNS Pharmaceuticals said Tuesday it has completed pilot manufacturing of a key active pharmaceutical ingredient for its brain tumor drug Berubicin, taking it closer to clinical trials.

Read more 
Thermo launches next-generation, compressor-free plate sealer

Thermo launches next-generation, compressor-free plate sealer

28 Jan 2020

Features new functionalities and capabilities making it versatile for a variety of both manual and automated microplate processing life science applications.

Read more 
First human trial of monoclonal antibody to prevent malaria opens

First human trial of monoclonal antibody to prevent malaria opens

28 Jan 2020

If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common.

Read more 
Piramal to expand Aurora facility with API manufacturing wing

Piramal to expand Aurora facility with API manufacturing wing

28 Jan 2020

Indian CDMO Piramal Pharma Solutions said Tuesday it will invest C$25 million to expand the capacity of its Aurora facility in Canada by 10,500 square feet to house a new wing for manufacturing active pharmaceutical ingredients (APIs).

Read more 
Merck invests in biotech development facility in Switzerland

Merck invests in biotech development facility in Switzerland

27 Jan 2020

€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing.

Read more